These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20030282)

  • 1. [Nevirapine as an important component of therapy for HIV infection].
    Kravchenko AV
    Vopr Virusol; 2009; 54(6):41. PubMed ID: 20030282
    [No Abstract]   [Full Text] [Related]  

  • 2. Nevirapine prevents vertical HIV-1 transmission.
    Porche DJ
    J Assoc Nurses AIDS Care; 2000; 11(1):82-5. PubMed ID: 10670010
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
    Kazennova EV
    Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal HIV prevention.
    Stephenson J
    JAMA; 1999 Aug; 282(7):625. PubMed ID: 10532854
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine.
    Lockman S; McIntyre JA
    Lancet; 2007 Nov; 370(9600):1668-70. PubMed ID: 17997152
    [No Abstract]   [Full Text] [Related]  

  • 6. Let nevirapine do what it does best.
    Huff B
    GMHC Treat Issues; 2002 Mar; 16(3):10-1. PubMed ID: 12004796
    [No Abstract]   [Full Text] [Related]  

  • 7. IOM: nevirapine study is reliable.
    James JS
    AIDS Treat News; 2005 Mar; (411):6. PubMed ID: 15906454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose jeopardizes long-term therapy.
    Clayden P
    GMHC Treat Issues; 2004; 18(11-12):6-8. PubMed ID: 15751136
    [No Abstract]   [Full Text] [Related]  

  • 9. Top stories of 2004. Perinatal transmission interventions: the benefits come with resistance.
    Coovadia H
    AIDS Clin Care; 2005 Jan; 17(1):2. PubMed ID: 15717360
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
    AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine warning on post-exposure prophylaxis.
    AIDS Treat News; 2001 Jan; (358):6-8. PubMed ID: 12173559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single dose theory.
    Huff B
    GMHC Treat Issues; 2004; 18(11-12):1-5. PubMed ID: 15751135
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-dose Nevirapine during pregnancy.
    Sax PE
    AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
    Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roundtable. Revisiting the role of single-dose nevirapine for preventing perinatal HIV transmission.
    Coovadia H; Fowler MG; Lockman S; McIntyre J
    AIDS Clin Care; 2005 Jul; 17(7):61-4. PubMed ID: 16110573
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-1 drug resistance and mother-to-child transmission.
    Morris L; Pillay C; Gray G; McIntyre J
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA advisory on nevirapine.
    AIDS Treat News; 2005 Jan; (409):7. PubMed ID: 15791716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.